APA aipamena

Becker, M. A., Hou, X., Tienchaianada, P., Haines, B. B., Harrington, S. C., Weroha, S. J., . . . Haluska, P. (2016). Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer. BMC Cancer.

Chicago Style aipamena

Becker, Marc A., Xiaonan Hou, Piyawan Tienchaianada, Brian B. Haines, Sean C. Harrington, S. John Weroha, Sriram Sathyanarayanan, and Paul Haluska. "Ridaforolimus (MK-8669) Synergizes With Dalotuzumab (MK-0646) in Hormone-sensitive Breast Cancer." BMC Cancer 2016.

MLA aipamena

Becker, Marc A., et al. "Ridaforolimus (MK-8669) Synergizes With Dalotuzumab (MK-0646) in Hormone-sensitive Breast Cancer." BMC Cancer 2016.